Prevnar 20 is a vaccine that helps protect against pneumococcal bacteria, which can cause pneumonia, blood and brain infections, and ear infections. It is given as a shot into the muscle. It works by teaching the body's immune system to recognize 20 types of these bacteria.
Every report comes from a Lived member, sent anonymously.
Have you tried Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine) for Hereditary Complement Deficiency Diseases?
Prevnar 20 is a vaccine that protects against pneumococcal bacteria (Streptococcus pneumoniae), a common cause of pneumonia, bloodstream infections, meningitis (infection of the lining around the brain and spinal cord) and ear infections in children. Its full name, pneumococcal 20-valent conjugate vaccine, means it covers 20 types, or serotypes, of these bacteria that cause much of the serious disease. In the US it is approved from 6 weeks of age to prevent serious invasive pneumococcal disease, for adults 18 and older to prevent pneumococcal pneumonia, and for young children up to age 5 to prevent ear infections caused by some of the types it covers. Federal vaccine advisers recommend a pneumococcal conjugate vaccine for every adult 50 or older who has not had one, and for adults 19 to 49 with conditions that raise their risk, such as diabetes, chronic heart, lung or liver disease, smoking, a weakened immune system, kidney failure or a cochlear implant. Prevnar 20 is also one of the vaccines recommended for the routine childhood series. It is one of several options. Capvaxive (a 21-type vaccine) is a single-shot alternative for adults, and Vaxneuvance (a 15-type vaccine) is followed a year or so later by a second vaccine, Pneumovax 23. Prevnar 20 builds on the older Prevnar 13, made the same way with 13 of the same types.
Pneumococcal bacteria are wrapped in a sugar coating, or capsule, that helps them hide from the immune system. Each serotype has a differently shaped capsule, which is why protection against one type does not carry over to another. Prevnar 20 contains purified pieces of the capsule sugar from 20 types. Each piece is attached to a harmless carrier protein made from a modified, non-toxic diphtheria protein. This linking, called conjugation, matters because sugar coatings on their own trigger a weak immune response, especially in babies. The carrier protein draws in helper immune cells, so the body makes stronger antibodies and builds longer-lasting immune memory. Those antibodies mark the bacteria so white blood cells can destroy them before they cause serious infection.
Prevnar 20 is a 0.5 mL injection into a muscle. It comes in a single-dose prefilled syringe and is given by a clinician or pharmacist. Adults need just one dose. If they have never had a pneumococcal conjugate vaccine, that single shot completes their pneumococcal vaccination, with no Pneumovax 23 needed afterward. Adults who previously had Prevnar 13 or Pneumovax 23 can usually still get it, but with a waiting period of at least one year (and five years in some combinations), so bring any vaccination records you have. Babies get four doses, at 2, 4 and 6 months and a booster at 12 to 15 months. Older children who missed doses, or who started with an older pneumococcal vaccine, follow a catch-up schedule that may need fewer doses. Prevnar 20 can be given at the same visit as other routine vaccines, including the flu shot.
Most reactions are mild and settle within a few days. In adults, pain at the injection site is very common, and many people also have muscle aches, tiredness or headache, and some have joint pain or swelling where the shot went in. Babies and toddlers are often fussy or sleepy for a day or two, may eat less and can have redness or swelling at the injection site or a fever. Severe allergic reactions are rare, and vaccination sites keep treatment on hand for them. Trouble breathing, swelling of the face or throat, widespread hives, a racing heartbeat or feeling faint after vaccination needs emergency care: call 911.
Do not get Prevnar 20 if you have had a severe allergic reaction to an earlier dose, to any of its ingredients or to any vaccine containing diphtheria toxoid (such as tetanus and diphtheria shots), since the carrier protein comes from diphtheria. People with a weakened immune system, including those taking medicines that suppress immunity such as chemotherapy, high-dose steroids or drugs used after an organ transplant, may make fewer antibodies and be less protected. They are still among those who benefit most from vaccination, so timing around treatment is worth planning with the care team. Some babies born prematurely have had brief pauses in breathing (apnea) after vaccine injections, so their care team decides when and where to give doses based on the baby's health. Information on Prevnar 20 in pregnancy is too limited to show whether there is any risk; an animal study found no harm to the fetus.
The vaccination itself takes only a moment, and most people go about their day afterward, perhaps with a sore arm. Antibodies build up over the following weeks; studies measured them a month after the shot. The vaccine reduces risk rather than eliminating it. In a large trial of adults 65 and older, its predecessor Prevnar 13 prevented about 45% of pneumonia cases and 75% of invasive infections caused by the types it covered. Prevnar 20's approval rests on showing it produces similar antibody levels, and for the seven newer types its pneumonia protection is still being confirmed. It does nothing against pneumonia caused by viruses, other bacteria or pneumococcal types it does not include, so getting sick with a cough and fever still deserves the usual medical attention. For most adults, one dose of Prevnar 20 is the last pneumococcal vaccine they will need, although recommendations may be reviewed as new vaccines appear and the bacteria change. In a few western US communities (Alaska, Colorado, Navajo Nation, New Mexico and Oregon), Prevnar 20 may be preferred over Capvaxive because a type it covers, serotype 4, is common there.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine), what you've noticed, or ask the community a question.